FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers



The U.S. Food and Drug Administration has approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian…



Source link

sticket2

Would you like to get the test?